James Brumley

James Brumley

James Brumley is a reformed stock broker and former Director of Research for an options-focused newsletter. He’s now primarily a freelance writer, tapping more than a decade’s worth of broad experience to help investors get more out of the market.

With a background in technical analysis as well as fundamental analysis, James writes with a multifaceted philosophy that combines the importance of company performance with the power of stock-trade timing. His commentary is as apt to focus on a chart as it is earnings, as he believes this dual approach is the only way an investor has a shot at consistently beating the market.

James’ work has appeared at several websites, including Street Authority, Motley Fool, Kapitall and Investopedia. When not writing as a journalist, James works on his book explaining his multipronged approach to investing.

Recent Articles

4 Big-Name Spinoffs We Might See Soon

They aren't the market's most-discussed potential spinoffs, but that's why they may hold the most upside ... the hidden value is yet to be priced in.

TWTR Stock Not Done Suffering From Twitter Fatigue

Before you buy TWTR stock on the dip, think about this stark reality that's never going to go away for Twitter.

5 Beaten-Down Stocks to Buy

Despite short-term pullbacks from these stocks, the underlying companies are still among the best stocks to buy for the long haul.

The Bears Should Clamp Down on Gold Prices Again … And Soon

Inflation, the Ukraine crisis, the end of QE and an improving economy are contributing to gold prices' volatility. Here's how it all could shake out.

2 Clear Signs That Biotechs and Pharmaceuticals Have Peaked

Pharmaceuticals and biotechs have been too hot for their own good, fueled by increasingly iffy M&A and an oddly high level of IPO activity.